Jennifer Q Pan

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: The Broad Institute, Inc., Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Q Pan. Retrieved from https://idiyas.com/inventor/jennifer-q-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 10.4

ph-index = 2

Forward Citations = 22(Granted Patents)

Company Filing History:

8 out of 490

The Broad Institute, Inc.

patents

5 out of 8,600

Massachusetts Institute of Technology

patents

5 out of 3,079

The General Hospital Corporation

patents

4. 4 out of 1,269

Dana-Farber-Cancer Institute Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428373 - Dopamine D2 receptor ligands (2025-09-30),

2. 12419885 - Kinase inhibitors and methods of use thereof (2025-09-23),

3. 11498896 - Dopamine D2 receptor ligands (2022-11-15),

4. 11052080 - Kinase inhibitors and methods of use thereof (2021-07-06),

5. 10752588 - Dopamine D2 receptor ligands (2020-08-25),

6. 10633336 - Dopamine D2 receptor ligands (2020-04-28),

7. 10137122 - Kinase inhibitors and methods of use thereof (2018-11-27),

8. 9265764 - Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders (2016-02-23),

9. 9096594 - Kinase inhibitors and methods of use thereof (2015-08-04),

Title: Innovations and Contributions of Jennifer Q Pan

Introduction: Jennifer Q Pan, based in Acton, MA, is a distinguished inventor with a strong background in pharmaceutical research and development. With a total of seven patents to her name, she has made significant contributions to the field of medical science, particularly in the area of receptor ligands and kinase inhibitors.

Latest Patents: Pan's most recent inventions include groundbreaking work on dopamine D2 receptor ligands. This invention pertains to novel ligands that show promise in treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity. Another notable patent from Pan focuses on kinase inhibitors, detailing compounds that are effective in inhibiting kinase activity, such as GSK3 and CK1. These compounds have potential applications for treating various kinase-mediated disorders, including neurological diseases, psychiatric disorders, metabolic disorders, and cancer.

Career Highlights: Throughout her career, Jennifer has worked at reputable institutions such as The Broad Institute and The General Hospital Corporation. These experiences have helped shape her innovative research, allowing her to contribute valuable knowledge to the scientific community.

Collaborations: During her time in the research field, Jennifer has collaborated with esteemed colleagues, including Edward Holson and Michael C Lewis. These partnerships have fostered an environment of innovation and have been instrumental in advancing their collective research projects.

Conclusion: Jennifer Q Pan's impressive portfolio of inventions and her collaborative efforts exemplify her commitment to advancing medical science. Her work in developing novel ligands and inhibitors not only highlights her innovative spirit but also reflects her dedication to addressing challenging health issues faced by society today.

Profile summary based on public USPTO records.